Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CANVAC DHP
- Development stage
- Unknown
- Lead developer
- Dyntec
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Subcutaneous
01
Overview
CANVAC DHP is a live attenuated trivalent veterinary vaccine developed by Dyntec for the active immunization of dogs. It is designed to protect against three major canine viral diseases: Canine Distemper, Infectious Hepatitis (caused by Canine Adenovirus Type 1), and Canine Parvovirus. The vaccine contains attenuated strains of the Canine Distemper Virus (CDV), Canine Adenovirus (CAV-2, which provides cross-protection against CAV-1), and Canine Parvovirus (CPV). Upon subcutaneous administration, the vaccine stimulates the dog's immune system to produce a protective response, preventing clinical signs and mortality associated with these pathogens. It is typically used in puppies and adult dogs as part of a core vaccination schedule.
- Brand names
- CANVAC DHP
- Other names
- CANVAC DHP
02
Targets
CAdV-2 (Canine adenovirus type 2)CDV (Canine distemper virus)
Beyond the preview
Go deeper on CANVAC DHP.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CANVAC DHP.